Cleveland Clinic opening pathogens research center in South Florida - S. Florida Business & Wealth

Cleveland Clinic opening pathogens research center in South Florida

Cleveland Clinic is establishing the Center for Global and Emerging Pathogens Research to broaden understanding of emerging pathogens—ranging from Zika virus to SARS-CoV-2 (which causes COVID-19)—and to expedite critically needed treatments and vaccines.

Serpil Erzurum, M.D., is chair of Cleveland Clinic’s Lerner Research Institute

The new center has been in the planning stages for 18 months and will span Cleveland Clinic’s Lerner Research Institute and the soon-to-open Cleveland Clinic Florida Research and Innovations Center in Port St. Lucie, Florida. A team of renowned experts will lead the center to advance research toward diseases such as COVID-19, highly pathogenic influenza, Dengue fever, AIDS and Zika virus-related conditions.

“Novel pathogens to which we have little or no immunity are a tremendous risk to global health,” said Serpil Erzurum, M.D., chair of the Lerner Research Institute. “We have some of the world’s top research experts in virology, immunology, genomics, population health and drug discovery coming together to form a team approach on infectious disease research.”

Leveraging Cleveland Clinic’s robust research infrastructure, the center’s researchers will uncover the scientific mechanisms of how SARS-Cov-2 and other pathogens cause disease. In addition, the researchers will closely collaborate with the newly established Cleveland Clinic BioRepository to have access to patient tissues and electronic medical record data through a large-scale secure database.  The new center will be supported in large part by philanthropy.

The research team will collaborate with the drug developers at Lerner Research Institute’s Center for Therapeutics Discovery to rapidly translate research findings into life-saving therapies and experts in the Populations Health Research Center to understand socioeconomic factors that affect risk of infection and poor outcomes.

In light of the global pandemic and in anticipation of the new center’s opening, Cleveland Clinic is ramping up research related to COVID-19. A research registry of nearly 10,000 patients is collecting data from patients tested for COVID-19 at Cleveland Clinic and there are plans to integrate the data with electronic medical records. The researchers will mine the data to inform other studies, such as the development of tools to predict risk and outcomes in patients.

Cleveland Clinic researchers published findings last month on a network-based prediction model using artificial intelligence to identify targets for drug repurposing in coronaviruses and COVID-19 specifically. Based on their findings, they prioritized 16 drugs and three drug combinations as potential treatments.

Other projects are uncovering how SARS-Cov-2 enters human cells, replicates and causes disease. A clinical trials committee has been formed to identify and prioritize the most promising therapies for mild to severe disease.

Joseph Iannotti, M.D., Ph.D., Cleveland Clinic Florida’s Chief of Staff and Chief Academic and Innovation Officer

In partnership with Cleveland Clinic Florida, the new center will also conduct research at the Florida Research and Innovation Center building, a state-of-the-art research facility, complete with a biosafety level 3 laboratory anticipated to open in summer 2020. The facility features 107,000-square feet of high-tech laboratory and office space situated on eight acres of land.

“The new Florida Research and Innovation Center will complement and expand clinical research underway throughout ClevelandClinic,” said Joseph Iannotti, M.D., Ph.D., Cleveland Clinic Florida’s Chief of Staff and Chief Academic and Innovation Officer. “Our vision is to create a research institute dedicated to taking bench discoveries and creating leading-edge diagnostics, preventatives and treatments for infectious disease, oncology and other pressing healthcare problems.”

“This new center will span our global healthcare system,” said James Young, M.D., Chief Academic Officer at Cleveland Clinic. “It will provide critical technologies and resources, empowering our clinicians and scientists to understand biological pathways and develop new treatments against the novel coronavirus and other dangerous pathogens.”

 

You May Also Like
Clamor Grows for More PPP

Anticipation is growing for Congress to free up another batch of PPP loans for small businesses as part of additional legislation to respond to the economic fallout from the COVID-19

Read More
Heroes of the Pandemic

By Clarissa Buch and Sally-Ann O’Dowd • photography (where indicated) by Eduardo Schneider “It’s so terrifying because as a pregnant female, I’m considered immuno-compromised. If I get infected, my immune

Read More
Business as usual

In the aftermath of our spring feature on how companies were dealing with the shutdown, businesses from all over South Florida continue to share their pandemic stories with SFBW. Here

Read More
Business as usual

[vc_row css_animation=”” row_type=”row” use_row_as_full_screen_section=”no” type=”full_width” angled_section=”no” text_align=”left” background_image_as_pattern=”without_pattern”][vc_column width=”2/3″][vc_column_text] By SFBW editorial staff Kevin Sheehan Jr. President, Bahamas Paradise Cruise Line Business backstory: The only two-night cruise sailing from the

Read More
Other Posts
Broward Education Foundation Names 2026 Sports Hall of Fame Inductees

Broward Education Foundation welcomed seven individuals and honored the Marjory Stoneman Douglas High School varsity baseball program for its six-year championship run during the recent Broward Sports Hall of Fame

Read More
Four men in suits stand in a row in front of a step-and-repeat banner for the Broward Education Foundation, with the man second from the right holding a glass award. South Florida Business & Wealth
Transworld M&A Advisors Completes Sale of Identillect Technologies to Caryco Tech

Transworld M&A Advisors, a subsidiary of Transworld Business Advisors(Transworld), the largest business brokerage firm in the world, announced the closing of the sale of Identillect Technologies, Inc. to Caryco Tech,

Read More
A man in a navy blue suit jacket and white collared shirt looking toward the camera. South Florida Business & Wealth
Forbes Names Holy Cross Health One of Florida’s Top 100 Employers

Holy Cross Health has been named to Forbes America’s Best Employers for Healthcare Professionals 2026 list for the second consecutive year and recognized on Forbes America’s Best Employers by State

Read More
A large group of hospital staff posing together, with one nurse in the center holding a large bouquet of white flowers. South Florida Business & Wealth
Carlos Boozer Named Chief Growth Officer of Impeccable

Impeccable announced that co-founder Carlos Boozer has taken on the full-time role of chief growth officer, expanding his involvement with the vertically integrated real estate and restaurant platform as it

Read More
A smiling man with a shaved head and a beard, wearing a gray suit, pink patterned shirt, and a dark necktie. South Florida Business & Wealth